Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.9.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.9.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BA.2.9.2NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BA.2.9.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.9.2NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.2.11EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.11NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BA.2.11NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BA.2.11NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.11NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.2.3.15EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.3.15NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BA.2.3.15NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BA.2.3.15NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.3.15NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.5.6.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.6.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BA.5.6.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BA.5.6.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.6.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.5.1.35EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.1.35NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BA.5.1.35NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BA.5.1.35NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.1.35NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
XBB.1.45EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.45NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XBB.1.45NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
XBB.1.45NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.45NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.177.31EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.31NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.177.31NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.177.31NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.31NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.160.26EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.160.26NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.160.26NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-5544.17Germany
B.1.160.26NWon-NGTTGCGACTACGTGATGAGG20552884928830R-1923.32South Korea
B.1.160.26NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
AY.39.1.2 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.39.1.2 (Delta)NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
AY.39.1.2 (Delta)NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
AY.39.1.2 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.39.1.2 (Delta)NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
AY.4.15 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.4.15 (Delta)NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
AY.4.15 (Delta)NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
AY.4.15 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.4.15 (Delta)NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used